Amy Newman
(Former)
1 - 8 out of 8Page size: 10
Publications
- 2017
- Published
Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: a clinical trial supporting anti-viral indications
Amy Newman, Gillian Grafton, John Curnow, Nicholas Barnes & John Gordon, Jan 2017, In: International Immunopharmacology. 42, p. 108-114Research output: Contribution to journal › Article › peer-review
- 2013
- Published
5-Chloroindole: a potent allosteric modulator of the 5-HT3 receptor: Allosteric modulation of the 5-HT3receptor
Amy Newman, Nikos Batis, Gillian Grafton, John Gordon, Keith Brain, Andrew Powell & Nicholas Barnes, Jul 2013, In: British Journal of Pharmacology. 169, 6, p. 1228-1238 11 p.Research output: Contribution to journal › Article › peer-review
- 2010
- Published
5-Chloroindole; a useful pharmacological tool to discriminate low intrinsic activity partial agonists from antagonists of the 5-HT3 receptor
Nikos Batis, Amy Newman, John Gordon & Nicholas Barnes, Nov 2010, Society for Neuroscience.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
- Published
- Published
IUPHAR (International Union of Basic and Clinical Pharmacology) website: 5-HT receptor nomenclature
Nicholas Barnes, Amy Newman, 1 Jan 2010Research output: Non-textual form › Web publication/site
- 2009
- Published
Quantitative PCR analysis of 5-HT receptor expression in tissue from the inferior colliculus and cochlear nucleus of an animal model of tinnitus
Amy Newman & Nicholas Barnes, 1 Jul 2009, p. P139P.Research output: Contribution to conference (unpublished) › Abstract
- Published
- 2008
- Published
The stability of the h5-HT3A receptor complex and the importance of C-terminus
Nikos Batis, Nicholas Barnes & Amy Newman, Dec 2008, British pharmacological Society.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution